Sara Marsal Barril News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 
Imagine a future in which earbuds could harness the power of the brain to regulate immune function. Such is the ambition of Nēsos, a startup launching out of stealth today, following months of development. The team is pioneering a new method for the treatment of rheumatoid arthritis using neuroplasticity-altering electrical fields, delivered to the target brain areas via earbuds to help regulate immune function. The company is also announcing $16.5 million in funding led by Mayfield Fund and results from its pilot clinical trial.
A dysregulated immune function, resulting in chronic inflammation, is at the root of autoimmune disorders. Existing pharmaceutical treatments require systemic delivery, risking adverse side effects from broad immunosuppression. The potential to target a pathway that enables the brain to regulate immune function, using the brain’s electrical language, could provide a new treatment option without the side-effect profile of existing thera ....

United States , San Diego , Israel General , San Francisco , Ursheet Parikh , Konstantinos Alataris , Sara Marsal Barril , Feinstein Institute , Mayfield Fund , American College Of Rheumatology , Mount Sinai , University Of California , Rheumatoid Arthritis , American College , Scientific Director , Hospital Vall , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , இஸ்ரேல் ஜநரல் , சான் பிரான்சிஸ்கோ , சாரா மார்சல் பாரில் , ஃபைன்ஸ்டீன் நிறுவனம் , மேஃபீல்ட் நிதி , அமெரிக்கன் கல்லூரி ஆஃப் வாத நோய் , ஏற்ற சினை , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா ,